Detección precoz e intervención activa en el deterioro cognitivo: Un reto sanitario

1. PETERSEN RC, SMITH GE, WARING SC, IVNIK RJ, TANGALOS EG, KOKMEN E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56(3):303-308. https://doi.org/10.1001/archneur.56.3.303

2. ALBERT MS, DEKOSKY ST, DICKSON D, DUBOIS B, FELDMAN HH, FOX NC et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):270-279. https://doi.org/10.1016/j.jalz.2011.03.008

3. PATNODE CD, PERDUE LA, ROSSOM RC, RUSHKIN MC, REDMOND N, THOMAS RG et al. Screening for cognitive impairment in older adults: An evidence update for the U.S. Preventive Services Task Force. [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. PMID: 32129963

4. SALARI N, LOTFI F, ABDOLMALEKI A, HEIDARIAN P, RASOULPOOR S, FAZELI J et al. The global prevalence of mild cognitive impairment in geriatric population with emphasis on influential factors: A systematic review and meta-analysis. BMC Geriatr 2025;25(1):313. https://doi.org/10.1186/s12877-025-05967-w

5. MATTHEWS FE, STEPHAN BC, MCKEITH IG, BOND J, BRAYNE C; Medical Research Council Cognitive Function and Ageing Study. Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree? J Am Geriatr Soc 2008;56(8):1424-1433. https://doi.org/10.1111/j.1532-5415.2008.01820.x

6. TIFRATENE K, ROBERT P, METELKINA A, PRADIER C, DARTIGUES JF. Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology 2015;85(4):331-338. https://doi.org/10.1212/wnl.0000000000001788

7. SAN MARTÍN-ERICE I, GARCÍA-VIVAR C, FURTADO-ERASO S, TAMAYO-RODRÍGUEZ I, SAN MARTÍN-RODRÍGUEZ L, SOTO-RUIZ N et al. Perfiles de alto riesgo de deterioro funcional y cognitivo tras el confinamiento por COVID-19 en residencias de ancianos:Estudio observacional multicéntrico. An Sist Sanit Navar 2026;49(2):e1165. https://doi.org/10.23938/assn.1165

8. LUXTON D, THORPE N, CRANE E, WARNE M, CORNWALL O, EL-DALIL D et al. Systematic review of the efficacy of pharmacological and non-pharmacological interventions for improving quality of life of people with dementia. Br J Psychiatry 2026;228(1):55-67. PMCID: PMC12722012. https://doi.org/10.1192/bjp.2025.11

9. Ministerio de Sanidad. Estrategia en Enfermedades Neurodegenerativas. Abordaje del Alzheimer y otras demencias. Madrid: Ministerio de Sanidad; 2021. https://www.sanidad.gob.es/areas/calidadAsistencial/estrategias/enfermedadesNeurodegenerativas/home.htm

10. GÓMEZ-SORIA I, CUENCA-ZALDIVAR JN, OLIVÁN-BLÁZQUEZ B, AGUILAR-LATORRE A, MAGALLÓN-BOTAYA RM, CALATAYUD E. Differential effects of computerized cognitive stimulation versus stimulating leisure activities on mood and global cognition in adults with subjective and mild cognitive impairment: A randomized controlled trial. An Sist Sanit Navar 2025;48(3):e1136. https://doi.org/10.23938/ASSN.1136

11. GÓMEZ-SORIA I, CUENCA-ZALDIVAR JN, OLIVÁN-BLÁZQUEZ B, AGUILAR-LATORRE A, MAGALLÓN-BOTAYA RM, CALATAYUD E. Long-term maintenance of the emotional benefits of cognitive stimulation in early-stage cognitive impairment. An Sist Sanit Navar 2026;49(2):e1164. https://doi.org/10.23938/ASSN.1164

12. HEBB DO. The Organization of Behavior. New York: Wiley; 1949. Brain Res Bull 1999;50(5-6):437. https://doi.org/10.1016/s0361-9230(99)00182-3